Researchers have developed an innovative nano-immune agonist that significantly improves immunotherapy outcomes for melanoma—a highly aggressive and hard-to-treat form of skin cancer.

Breast cancer is becoming increasingly treatable, but in some cases the disease can resurface even decades after a patient ...

Adjuvant treatment with dabrafenib and trametinib may be more effective than observation or adjuvant treatment with a PD-1 inhibitor in patients with stage IIIA melanoma.

Several dermoscopic findings may help identify low-grade dysplastic nevi from other lesions, though the performance of the methods used was poor.